Literature DB >> 519960

Clonidine and sympathetic activity during sleep.

T J Maling, C T Dollery, C A Hamilton.   

Abstract

1. Blood pressure, heart rate, plasma noradrenaline and electroencephalographic variables were measured simultaneously during sleep in five healthy males before and after slow-release clonidine (300 micrograms orally) or placebo. 2. The blood pressure fall during sleep correlated significantly with the depth of sleep. 3. Clonidine significantly reduced systolic blood pressure during sleep and profoundly reduced total paradoxical sleep duration. 4. Plasma noradrenaline declined progressively during the sleep period and concentrations were significantly lower after clonidine compared with placebo.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 519960     DOI: 10.1042/cs0570509

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  6 in total

Review 1.  Assessment of sympathetic cardiovascular influences in man: haemodynamic and humoral markers versus microneurography.

Authors:  G Mancia; G Grassi
Journal:  Clin Auton Res       Date:  1991-09       Impact factor: 4.435

2.  The haemodynamic and hormonal responses after clonidine occur independently of sedation in essential hypertension.

Authors:  J S Kooner; W S Peart; C J Mathias
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

3.  The Fourth Lilly Prize Lecture, University of Aberdeen, September 1980. The clinical pharmacology of clonidine and related central antihypertensive agents.

Authors:  J L Reid
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

Review 4.  Central nervous system plus autonomic nervous system disorders responsible for gastrointestinal and pancreatobiliary diseases.

Authors:  Fuad Lechin; Bertha van der Dijs
Journal:  Dig Dis Sci       Date:  2008-07-16       Impact factor: 3.199

5.  The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects.

Authors:  A D Struthers; M J Brown; E F Adams; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

6.  Effects of an oral dose of l-glutamic acid on circulating neurotransmitters: Possible roles of the C1(Ad) and the A5(NA) pontomedullary nuclei.

Authors:  Fuad Lechin; Bertha van der Dijs; Betty Pardey-Maldonado; Jairo E Rivera; Marcel E Lechin; Scarlet Baez
Journal:  J Exp Pharmacol       Date:  2010-02-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.